Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CaP-D is a veterinary nutritional supplement developed by Pepco Pharma, specifically formulated for poultry, dairy, and livestock. It provides a concentrated source of calcium, phosphorus, and vitamin D, which are essential for skeletal development, eggshell quality in poultry, and metabolic health in dairy animals. Vitamin D in the formulation acts as an agonist for the vitamin D receptor, facilitating the intestinal absorption of calcium and phosphorus. The supplement is designed for oral administration, typically by mixing it into the animals' feed or drinking water, to prevent or treat mineral deficiencies and support overall productivity and bone health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CaP-D.